---
title: Limited usefulness of neurocognitive functioning indices as predictive markers
  for treatment response to methylphenidate or neurofeedback@home in children and
  adolescents with ADHD
date: '2024-02-05'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38312916/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240205170658&v=2.18.0
source: heidelberg[Affiliation]
description: 'INTRODUCTION: Earlier studies exploring the value of executive functioning
  (EF) indices for assessing treatment effectiveness and predicting treatment response
  in attention-deficit/hyperactivity disorder (ADHD) mainly focused on pharmacological
  treatment options and revealed rather heterogeneous results. Envisioning the long-term
  goal of personalized treatment selection and intervention planning, this study comparing
  methylphenidate treatment (MPH) and a home-based neurofeedback ...'
disable_comments: true
---
INTRODUCTION: Earlier studies exploring the value of executive functioning (EF) indices for assessing treatment effectiveness and predicting treatment response in attention-deficit/hyperactivity disorder (ADHD) mainly focused on pharmacological treatment options and revealed rather heterogeneous results. Envisioning the long-term goal of personalized treatment selection and intervention planning, this study comparing methylphenidate treatment (MPH) and a home-based neurofeedback ...